跳到正文
原文
MedPage Today·· 16 天前AI 评分60

脑损伤造就音乐天才;长新冠改善;痴呆与谵妄

Brain Injury Creates Musical Genius; Long COVID Improvement; Dementia and Delirium

AI 导读

《纽约时报》报道了脑损伤造就音乐天才的案例;Bright Minds Biosciences的药物BMB-101临床试验受阻;uniQure的基因疗法申请获受理;长新冠患者症状改善;婴儿癫痫发病率研究;肺动脉高压影像学研究;氟喹诺酮与头孢菌素对周围神经病变风险的比较;住院谵妄与痴呆关联;耶鲁纽黑文医院因认知测试诉讼进入审判阶段。

正文

— News and commentary from the world of neurology and neuroscience

by Judy George, Deputy Managing Editor, MedPage Today

November 3, 2026 • 2 min read

The New York Times detailed the story of Edward Freytag, whose traumatic brain injury made him a musical genius.

Bright Minds Biosciences said the FDA placed a partial clinical hold on its investigational drug BMB-101, which is being studied to treat seizures associated with developmental and epileptic encephalopathies, after identifying toxicity in mice.

And uniQure said the agency accepted its biologics license application for the company's Huntington's disease gene therapy candidate ifezuntirgene inilparvovec (AMT-130), with a decision expected next May.

Half of long COVID patients had meaningful symptom improvement within 3 years, prospective data from the RECOVER-Adult study showed. (Annals of Internal Medicine)

The global pooled cumulative incidence of infantile-onset epilepsies within the first 2 years of life was 236 per 100,000 live births, according to a systematic review and meta-analysis of 86 studies. (JAMA Neurology)

Reduced cerebellar white matter volume, thinner frontal gyri, and weakened cerebellar-frontal connectivity were seen in people with pulmonary hypertension but not in other heart or lung diseases, an imaging study found. (Journal of Clinical Investigation)

Fluoroquinolones carried no greater risk of peripheral neuropathy versus cephalosporins, an analysis of U.K. primary care records showed. (Neurology)

Delirium during hospitalization was strongly linked with dementia and mild cognitive impairment in subsequent years, a cohort study suggested. (JAMA Neurology)

NBC News producer Susan Kroll shared her personal journey with early Alzheimer's disease. (Today)

The Equal Employment Opportunity Commission's lawsuit against Yale New Haven Hospital in Connecticut over cognitive testing of physicians 70 and older heads to trial after a federal judge denied summary judgment motions. (Becker's Physician Leadership)

Neuroscientist Gerald Fischbach, MD, former director of the NIH's National Institute of Neurological Disorders and Stroke and founding director of the Simons Foundation Autism Research Initiative, died at age 87.

来源:MedPage Today · medpagetoday.com